Peritoneal Neoplasm — Trials

Peritoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

592 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–71 of 71 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07480954	Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)(DUAL-OV-CAR-NK)	recruiting	Phase 1 / Phase 2	36	Beijing BiotechINDUSTRY	1	Mar 18, 2026	clinicaltrials
NCT04781088	Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	active not recruiting	Phase 2	38	Floor Backes, MDOTHER	1	Feb 11, 2026